Home › Sickle Cell Disease › Arkansas
Sickle Cell Disease clinical trials in Arkansas
3 studies for Sickle Cell Disease are looking for participants at sites in Arkansas.
Cities in Arkansas
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- UAMS Medical Center, Little Rock
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07224360A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Arkansas Children's Hospital, Little Rock
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT06612268ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Arkansas Center for Bleeding Disorders, Little Rock
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.